# Phase 28B SOAR End-to-End Acceptance

## Technical trace
The Phase 27 real execution test covers all ten active deployments and both beta-lactamase encoded values. The complete governed runtime trace executed in Phase 27 used synthetic Doxycycline/Streptococcus data:

`exact deployment -> real model -> normalized output -> DecisionFusionEngine -> clinical rules -> explanation -> audit event`

Observed result: plugin output `R`, fusion recommendation `Doxycycline`, three clinical rule results, one explanation evidence driver, SUCCESS audit event, and `SYNTHETIC_TEST_DATA` provenance.

## Clinician input boundary
The frontend contract exposes `BetaLactamaseStatus` with `POSITIVE`/`NEGATIVE`. `Beta_Lactamase_enc` remains internal; numeric bypass is rejected by resolver tests. Missing fields, unknown deployments, and invalid enums fail closed.

## Authenticated workflow
The clinician-facing authenticated browser workflow was not executed. Tenant context and RBAC are enforced in backend dependencies and governed plugin tests, but browser acceptance is not claimed.

## Status
`PARTIAL`: real backend/plugin/fusion/explanation/audit construction is proven with synthetic data; authenticated clinician UI and audit retrieval remain unverified.
